Related Experiment Video
Updated: Sep 9, 2025

05:33
Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication
Published on: July 5, 2024
789
Developing Methods for the Synthesis of Ligand-Oligonucleotide Conjugates for Drug Discovery Applications
1Graduate School of Pharmaceutical Sciences, The University of Osaka.
Chemical & Pharmaceutical Bulletin
|August 31, 2025
Summary
Researchers are developing new methods for synthesizing artificial nucleic acids, focusing on ligand-oligonucleotide conjugates. These conjugates are promising for improving oligonucleotide therapeutics and advancing drug discovery.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Drug Discovery
Background:
- Oligonucleotide therapeutics are gaining prominence in medicine.
- Developing functional artificial nucleic acids is a global research focus.
- Synthesizing artificial nucleic acids often requires lengthy starting sequences, complicating structural optimization.
Purpose of the Study:
- To address the challenges in structurally optimizing oligonucleotide therapeutics.
- To introduce research focused on developing reactions using oligonucleotides as starting materials.
- To highlight the significance of ligand-oligonucleotide conjugates in drug delivery and discovery.
Main Methods:
- Developing novel synthetic reactions utilizing oligonucleotides as starting materials.
- Investigating the properties and applications of ligand-oligonucleotide conjugates.
- Reviewing existing research and presenting the authors' work in this area.
Main Results:
- Ligand-oligonucleotide conjugates show potential as advanced drug-delivery systems.
- These conjugates can enhance the efficacy of oligonucleotide therapeutics.
- They also serve as valuable tools in DNA-encoded library-based drug discovery.
Conclusions:
- Ligand-oligonucleotide conjugates represent a promising strategy for improving oligonucleotide-based therapies.
- The development of efficient synthetic methods is crucial for advancing this field.
- This research contributes to the growing field of artificial nucleic acid therapeutics.
More Related Videos
Related Concept Videos
Ligand Binding Sites
13.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.1K
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Complexometric Titration: Ligands
1.1K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
1.1K
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Phase II Conjugation Reactions: Overview
309
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
309
Labeling DNA Probes
8.3K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
8.3K

